A new and improved industrially viable manufacturing process for valsartan, an antihypertension drug, is described.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: